🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsMy pharmacist tried to explain the mechanism and my eyes glazed over — 12 month update Page 3

My pharmacist tried to explain the mechanism and my eyes glazed over — 12 month update

sarah_nash92 Mon, Feb 2, 2026 at 6:30 PM 29 replies 1,533 viewsPage 3 of 6
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Feb 3, 2026 at 5:56 AM#11
andrew_nyc said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

Happy to go further on any of that.

Last edited: Feb 3, 2026 at 6:56 AM
43 16mona_PHX, andrew_nyc, Dr.EndoEP and 40 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Feb 3, 2026 at 12:34 PM#12
wendy_avl said:
The pharmacokinetics explain nearly every practical question asked here.

Bookmarking. The distinction being drawn above is the one nobody else makes. Printing the relevant bit and taking it with me.

44 17maya_sedona, stefan_berlin, Dr.EM_Chicago and 41 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Feb 3, 2026 at 7:12 PM#13
andrew_nyc said:
Receptor pharmacology relevant to the pharmacology: semaglutide is a GLP-1R agonist with a C-18 fatty acid chain that enables albumin binding (>99%),…

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

45 18ingrid_STO, pete_nash, hank_denver and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Feb 4, 2026 at 1:50 AM#14

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Feb 4, 2026 at 2:50 AM
46 19hans_munich, jason_sac26, chris_chi24 and 43 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 4, 2026 at 8:27 AM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Carry on.

Last edited: Feb 4, 2026 at 10:27 AM
47 20PurityPaulOR, MaxMetOK, MounjBrad and 44 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register